The Role of Methicillin-Resistant Staphylococcus aureus in Orthopaedic Implant Surgery

References

• Kusachi S, Sumiyama Y, Kawai K, et al. New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection. Surg Today 1999; 29: 724–729.
   PubMed Web of Science ®Google Scholar
• Gwynne-Jones DP, Stott NS. Community acquired methicillin-resistant Staphylococcus aureus: a cause of muscu-loskeletal sepsis in children. J Paediatr-Orthop 1999; 19: 413–416.
   PubMed Web of Science ®Google Scholar
• Sanderson PJ. Infection in orthopaedic implants. J Hosp Infect 1991; 18: Suppl A: 367-375.
   Google Scholar
• Mini E, Nobili S, Periti P. Methicillin-resistant staphylo-cocci in clean surgery. Drugs 1997; 54, Suppl. 6: 39-52.
   Google Scholar
• The Hospital Infection Control Practice Advisory Committee. Recommendations for preventing the spread of vancomycin resistance: recommendations from the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Contr 1995; 23: 87–94.
   Google Scholar
• MacKinnnon MM, Allen KD. Long-term MRSA carriage in hospital patients. J Hosp Infect 2000; 46: 216–221.
   PubMed Web of Science ®Google Scholar
• Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the car-riage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994; 19: 1123–1128.
   PubMed Web of Science ®Google Scholar
• Beaujean DJ, Blok HE, Weersink AJ, Verhoef J. Long-term methicillin-resistant Staphylococcus aureus (MRSA) car-riage and tagging of patient records: in Utrecht you're not MRSA-positive for life. J Hosp Infect 1997; 37: 338–339.
   PubMed Web of Science ®Google Scholar
• Nishi J-I, Shirao K, Ito H, et al. Difference in incidence and transmission mode of methicillin-resistant Staphylococcus aureus among surgery, orthopedics, and pediatrics wards: a prospective study at a University Hospital. Infect Contr Hosp Epidemiol 1998; 19: 107–109.
   PubMed Web of Science ®Google Scholar
• Zulian C, Descamps PH, Samyn B, Lemerle JP, Galliot O. Enquete d'incidence des infections nosocomiales et evalua-tion du portage de Staphylococcus aureus resistant a la meti-cilline dans un service de chirurgie orthopedique. Path Biol 1999; 47: 445–448.
   PubMed Web of Science ®Google Scholar
• Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50–55.
   PubMed Web of Science ®Google Scholar
• Sanderson PJ. Orthopaedic implant infections: can they be reduced still further? Editorial review. Curr Opin Infect Dis 1994; 7: 469–470.
   Web of Science ®Google Scholar
• Williams REO, Jevons MP, Shooter RA, et al. Staphylococci and sepsis in hospital patients. Br Med J 1959; ii: 658–662.
   Web of Science ®Google Scholar
• Williams REO. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27: 56–71.
   PubMedGoogle Scholar
• Weinstein HJ. The relation between the nasal-staphylo-coccal-carrier state and the incidence of postoperative compli-cations. N Engl J Med 1959; 260: 1303–1310.
   PubMed Web of Science ®Google Scholar
• Bengtsson S, Hambraeus M, Laurell G. Wound infec-tion after surgery in a modern operating suite. J Hyg Camb 1979; 83: 41–46.
   PubMedGoogle Scholar
• Solberg CO. A Study of carriers of Staphylococcus aureus. Acta Medica Scand 1965; 178, Suppl A: 436-450.
   Google Scholar
• White A, Smith J. Nasal reservoir as the source of extranasal staphylococci. Antimicrob Agents Chemother 1963; 30: 675–683.
   Google Scholar
• White A. Relation between quantitative nasal culture and dissemination of staphylococci. J Lab Clin Med 1961; 58: 273–277.
   PubMed Web of Science ®Google Scholar
• Barrett SP.The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus in an orthopaedic unit. J Hosp Infect 1990; 15: 137–142.
   PubMed Web of Science ®Google Scholar
• Hill RLR, Duckworth G, Casewell MW. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988; 22: 377–384.
   PubMed Web of Science ®Google Scholar
• Reagan D, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114: 101–106.
   PubMed Web of Science ®Google Scholar
• Mest DR, Wong DH, Shimoda KJ, et al. Nasal coloni-sation with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 1994; 78: 644–650.
   PubMed Web of Science ®Google Scholar
• Thurn JR, Crossley KB, Gerdts A, and Baken L. Dynamics of coagulase-negative staphylococcal colonization in patients and employees in a surgical intensive care unit. J Hosp Infect 1992; 20: 247–255.
   PubMed Web of Science ®Google Scholar
• Hudson IRB. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 1994; 27: 81–98.
   PubMed Web of Science ®Google Scholar
• Boelaert JR, van Landuyt HW, Godard CA, et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemia in haemodialysis patients. Nephrol Dialysis Transplant 1993; 8: 235–239.
   PubMed Web of Science ®Google Scholar
• Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on haemodialy-sis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315: 91–96.
   PubMed Web of Science ®Google Scholar
• The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during perioneal dialysis. J Am Soc Nephrol 1996; 7: 2403–2408.
   PubMed Web of Science ®Google Scholar
• Casewell MW. The nose: an underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998; 40: Suppl 3-11.
   Google Scholar
• Bellman B, Brandt FS, Holtmann M, Bebell WR. Infection with methicillin-resistant Staphylococcus aureus after carbon dioxide resurfacing of the face. Successful treat-ment with minocycline, rifampicin, and mupirocin ointment. Dermatol-Surg 1998; 24: 279–82.
   Google Scholar
• Yano M, Doki Y, Inoue M, Tsujinaka T, Shiozaki M, Monden M. Preoperative intranasal mupirocin ointment signif-icantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg-Today 2000; 30: 16–21
   PubMed Web of Science ®Google Scholar
• Rahman M, Noble WC, Cookson B. Mupirocin-resis-tant Staphylococcus aureus. Lancet 1987; ii: 387–389.
   Google Scholar
• Wilson APR, Grtineberg RN, Treasure T, and Sturridge MF. The effect of antibiotic prophylaxis and topical antiseptics on the bacterial flora of the skin after cardiac surgery. J Hosp Infect 1987; 10: 58–66.
   PubMed Web of Science ®Google Scholar
• Boelaert JR, van Landuyt HW, de Baere YA, Derudder MM, Gordts BZ. What is the risk of resistance during long-term chemoprophylaxis of Staphylococcus aureus bac-teremias in hemodialysis by nasal mupirocin? 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 28 September — 1 October, 1997: Abstr. J117.
   Google Scholar
• Schentag JJ, Hyatt JM, Carr JR, et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibi-otic management and infection control. Clin Infect Dis 1998; 26: 1204–1214.
   PubMed Web of Science ®Google Scholar
• Kluytmans J, Pieper M, Verbrugh H. In vitro suscepti-bility of Staphylococcus aureus against mupirocin. 20th International Conference on Chemotherapy, Sydney, Australia, 29 June — 3 July, 1997: Abstr 2301.
   Google Scholar
• Caelli M, Porteous J, Carson CF, Heller R, Riley TV. Tea tree oil as an alternative topical decolonization agent for methicillin resistant Staphylococcus aureus. J Hosp Infect 2000; 46: 236–237.
   PubMed Web of Science ®Google Scholar
• Mollan RAB, Haddock M, Webb CH. Teicoplanin vs cephamandole for antimicrobial prophylaxis in prosthetic joint implant surgery (preliminary results). Eur J Surg 1992; Suppl 567: 19-22.
   Google Scholar
• Periti P, Stringa G, Donati L, Mazzei T, Mini E, Novelli A. Teicoplanin—its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Eur J Surg 1992; Suppl 567: 3-8.
   Google Scholar
• Suter F, Avae A, Fusco U, Gerundini M, Carprioli S, Maggiolo F. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 1994; 13: 793–6.
   PubMed Web of Science ®Google Scholar
• Sanderson PJ. Prophylaxis in orthopaedic implant surgery—should we use a glycopeptide? J Antimicrob Chemother 1998; 41: 322–325.
   PubMed Web of Science ®Google Scholar
• James PJ, Butcher IA, Gardner ER, Hamblen DL. Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg 1994; 76B: 725–727.
   Web of Science ®Google Scholar
• Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of 106 infec-tions. J Bone Joint Surg 1996; 78A: 512–523.
   Web of Science ®Google Scholar
• Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylax-is. J Infect Dis 1983; 147: 642–649.
   PubMed Web of Science ®Google Scholar
• Powell M, Sanderson PJ. Resistant coagulase negative staphylococci in hospital patients. J Hosp Infect 1987; 9: 48–53.
   PubMed Web of Science ®Google Scholar
• Schaad HJ, Chuard C, Vaudaux P, Waldvogel FA, Lew DP. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimen-tal foreign body infection by methicillin-resistant Staphylococcus aureus. Atimicrobial Agents and Chemotherapy. 1994 38: 1703–1710.
   PubMed Web of Science ®Google Scholar
• Aspinall SL, Friedland DM, Yu VL, Rihs JD, Muder RR. Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: Combination antibiotic therapy with evaluation by serum bactericidal titers. Ann Pharmacother 1995; 29: 694–697.
   PubMed Web of Science ®Google Scholar
• Moorhouse EC, Mulvihill TE, Jones E, et al. The in-vitro activity of some antimicrobial agents against methicillin resistant Staphylococcus aureus. J Antimicrob Chemother 1985; 15: 291–296.
   PubMed Web of Science ®Google Scholar
• Kucers A, Bennett NM. The use of antibiotics. 4th ed. London, UK; Heineman 1987: 111, 1047, 1069, 1252.
   Google Scholar
• Livermore DM. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use? J Antimicrob Chemother 2000; 46: 347–350.
   PubMed Web of Science ®Google Scholar
• Shah P. Synercid for MRSA. Results of the European emergency use programme. Int J Antimicrob Agents 2000; in Press.
   Google Scholar
• Cupo-Abbott J, Louie SG, Rho JP. A synthetic oxazo-lidinone antimicrobial for treatment of serious gram-positive infections. Formulary 2000; 35: 483–497.
   Google Scholar